ICU Medical (NASDAQ:ICUI) Shares Break Above Fifty Day Moving Average – Should You Sell?

ICU Medical, Inc. (NASDAQ:ICUI)’s stock price passed above its 50-day moving average during trading on Wednesday. The stock has a 50-day moving average of $164.97 and traded as high as $166.65. ICU Medical shares last traded at $166.39, with a volume of 156,425 shares changing hands.

Wall Street Analyst Weigh In

A number of analysts recently commented on the company. Wall Street Zen raised ICU Medical from a “buy” rating to a “strong-buy” rating in a research note on Saturday, August 8th. BTIG Research boosted their target price on shares of ICU Medical from $170.00 to $200.00 and gave the company a “buy” rating in a research note on Friday, August 7th. Weiss Ratings upgraded shares of ICU Medical from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, October 8th. Piper Sandler upped their target price on shares of ICU Medical from $163.00 to $195.00 and gave the company an “overweight” rating in a report on Friday, August 7th. Finally, Needham & Company LLC raised their price target on shares of ICU Medical from $165.00 to $187.00 and gave the stock a “buy” rating in a research note on Friday, August 7th. Two equities research analysts have rated the stock with a Strong Buy rating, four have given a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $192.80.

ICU Medical Stock Up 2.0%

The company has a debt-to-equity ratio of 0.56, a current ratio of 2.43 and a quick ratio of 1.21. The stock has a market cap of $4.16 billion, a price-to-earnings ratio of 141.01, a price-to-earnings-growth ratio of 2.10 and a beta of 0.86. The firm’s 50-day moving average is $164.97 and its 200 day moving average is $148.75.

ICU Medical (NASDAQ:ICUI) last posted its quarterly earnings results on Thursday, August 6th. The medical instruments supplier reported $2.37 EPS for the quarter, beating the consensus estimate of $1.91 by $0.46. ICU Medical had a net margin of 1.39% and a return on equity of 7.91%. The firm had revenue of $547.88 million for the quarter, compared to analyst estimates of $533.44 million. During the same quarter last year, the firm posted $2.10 earnings per share. ICU Medical’s revenue for the quarter was up .5% compared to the same quarter last year. ICU Medical has set its FY 2026 guidance at 8.600-9.000 EPS. Sell-side analysts anticipate that ICU Medical, Inc. will post 7.22 earnings per share for the current fiscal year.

Insider Transactions at ICU Medical

In other ICU Medical news, insider Ben Sousa sold 2,250 shares of ICU Medical stock in a transaction on Wednesday, August 12th. The shares were sold at an average price of $178.32, for a total value of $401,220.00. Following the completion of the transaction, the insider owned 3,076 shares of the company’s stock, valued at $548,512.32. The trade was a 42.25% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, VP Virginia Sanzone sold 4,856 shares of the business’s stock in a transaction on Thursday, September 3rd. The shares were sold at an average price of $168.69, for a total transaction of $819,158.64. Following the sale, the vice president owned 14,604 shares of the company’s stock, valued at approximately $2,463,548.76. The trade was a 24.95% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 21,830 shares of company stock valued at $3,905,003 over the last quarter. Insiders own 2.10% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the business. Allworth Financial LP bought a new stake in shares of ICU Medical during the 2nd quarter valued at about $26,000. Versant Capital Management Inc raised its stake in ICU Medical by 26.2% during the third quarter. Versant Capital Management Inc now owns 313 shares of the medical instruments supplier’s stock worth $50,000 after acquiring an additional 65 shares during the period. Public Employees Retirement System of Ohio acquired a new stake in ICU Medical during the second quarter worth about $51,000. Rockefeller Capital Management L.P. raised its stake in ICU Medical by 21.6% during the fourth quarter. Rockefeller Capital Management L.P. now owns 823 shares of the medical instruments supplier’s stock worth $117,000 after acquiring an additional 146 shares during the period. Finally, Nykredit A S bought a new position in ICU Medical in the second quarter worth about $135,000. 96.10% of the stock is currently owned by institutional investors.

ICU Medical Company Profile

ICU Medical, Inc develops, manufactures and sells medical devices and systems used in infusion therapy, critical care and oncology. Its products are designed to support the delivery of fluids, medications and nutrition while helping healthcare providers improve safety and efficiency in clinical settings.

The company’s portfolio includes infusion pumps, dedicated and non-dedicated administration sets, needle-free connectors, intravenous solutions and other infusion consumables. ICU Medical also offers products for critical care monitoring and vascular access, as well as closed-system transfer devices and related technologies used in the preparation and administration of hazardous drugs.

Founded in 1984, ICU Medical has expanded through internal development and acquisitions, including the acquisition of Hospira’s infusion systems business in 2017 and Smiths Medical in 2022.